Multiple myeloma

Introduction

This information is produced and provided originally by the National Cancer Institute (NCI). We only provide general information and advice from medical professionals should be followed. More information is available on the NCI-website at www.cancer.gov This information was last updated by NCI in July 2014.

 

A type of cancer that begins in plasma cells (white blood cells that produce antibodies). Also called Kahler disease, myelomatosis, and plasma cell myeloma.

 

 

 

 

The Anticancer Fund content will follow shortly. Following link will provide you with reliable information.

Synonyms

Multiple myeloma

Myeloma

Kahler disease

Plasma Cell Myeloma

Myelomatosis

Blood cancer

Bloodcancer

 

Therapies by type

The following list of treatments is based on what we have found in scientific studies about cancer. More information about the listed therapies can be found under the tab THERAPIES. For registered drugs, radiotherapy and surgical interventions, approval by the authorities is given.

Cell-based therapies

Administration to patients of their own or someone else’s manipulated human cells. More

Clinical trials

A clinical trial is a research study conducted with patients to evaluate whether a new treatment is safe (safety) and whether it works (efficacy). Clinical trials are performed to test the efficacy of drugs but also non-drug treatments such as radiotherapy or surgery and combinations of different treatments. Clinical trials take place in all kinds of hospitals and clinics, but mostly in academic hospitals. They are organized by researchers and doctors.

The Anticancer Fund provides a tool to search for phase III clinical trials by type of cancer and by country. For Belgium, the Netherlands, Switzerland, Luxembourg, France and the UK, the Anticancer Fund provides contacts to get more information about the phase III clinical trials currently ongoing. Discuss the possibilities of participating in one of these clinical trials with your doctor.

The list of the phase III clinical trials for multiple myeloma is available here.